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Alport’s Syndrome is characterized by the presence 
of renal, hearing and visual disorders. Objective: To 
characterize the TOAE and the MOES activity (suppression 
effect) in individuals with Alport’s Syndrome. Material and 
Method: This is a prospective study of a sample included 
ten individuals with a diagnosis of Alport’s Syndrome. 
MOES recording was made in the presence and absence of 
contralateral stimulation (CLS) stimulation using the computer 
software ILO 92 - Otodynamics. Results: TOAE was present 
in the global response (A) and in frequency ranges of 1000, 
1500, 2000 and 3000 Hz in 4 individuals (40%), and absent 
in 6 individuals (60%) with hearing loss. We observed no 
responses at 4000 Hz in the right and left ears. Individuals 
that presented global responses to TOAE also suppressed 
that response when there was noise. Conclusion: The 
suppression effect also occurs with TOAE, suggesting that 
the hearing loss is predominantly the result of cochlear 
dysfunction. 
Keywords: otoacoustic emissions, acoustic stimulation, 
hereditary nephritis, auditory perception.
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INTRODUCTION
Hearing is important for communication between 
human beings in their environment. Hearing enables hu-
man beings to receive and to interpret sound information 
from the external milieu, and fosters language, learning 
and the transmission of ideas by oral and/or written com-
munication. When hearing fails, the relation with the world 
of sound is compromised.
One of the genetic syndromes that include hearing 
loss and its consequences is Alport’s syndrome. This 
syndrome is characterized by renal, auditory and visual 
alterations.1,13
Nephritis is the most common finding,1 and usually 
presents in adolescence with intermittent proteinuria and/
or hematuria, which progresses to renal failure. Althou-
gh in most cases inheritance is X-linked (80% of cases), 
transmission may be heterogeneous. The frequency and 
severity is higher in men when inheritance is X-linked. 
The onset of renal failure and hearing loss may occur at 
any age. Similar phenotypes are expected within the same 
family. The dominant autossomic inheritance and autos-
somic recessive inheritance forms are described below, in 
order of frequency. 
Changes may reside in a structural gene in a locus 
responsible for the basal glomerular membrane, the ear, 
and the optic capsule. This locus is responsible for the 
composition of collagen in the basal membrane of the 
aforementioned organs. In 1982 it was found that the 
disease occurs due to a genetic error in which certain 
basal membrane structures are not formed (the basal 
membrane remains in a fetal state). Thus, there seems to 
be a mutation that leads to altered production of type IV 
collagen, an essential component of the basal membrane 
in various organs.
Ophthalmologic alterations are present in 15% of 
patients. The most common finding is the anterior lenti-
conus in the lens, seen clinically as an image similar to a 
drop of oil in water.    
Sensorineural hearing loss is typically bilateral, sym-
metric and progressive, starting in adolescence in 60% of 
men and 40% of women with Alport’s syndrome.7 
Gregg and Becker8 conducted histopathology stu-
dies in 1963, which demonstrated vascular stria and ciliated 
cell degeneration, especially in the basal portion of the 
cochlea, as well as absence of the tectorial membrane. 
The idea for is paper arose because we found 
no references in literature on the aspect of transitory 
otoacoustic emissions (TOAE) and activity of the medial 
olivocochlear efferent system (MOES) in patients with 
Alport’s syndrome. 
The aim of this study, therefore, was to identify 
TOAE and MOES activity (suppression effect) in patients 
with Alport’s syndrome.
 MATERIAL AND METHODS
This study was carried out in the Central Auditory 
Processing research line of the Postgraduate program in 
Human Communication Disorders of the Federal University 
of São Paulo, approved by the ethics committee of this 
institution, protocol # 0240/03. 
The group we studied included patients with an 
established diagnosis of Alport’s syndrome. Alport’s syn-
drome was diagnosed by the presence of typical electronic 
microscopic histological alterations in renal biopsies, and 
by the coexistence of renal histological alterations and 
auditory and/or ocular involvement which are common 
in this syndrome.
The sample included ten patients (nine men and 
one woman) with Alport’s syndrome, aged between 13 
and 54 years. These patients had an established medical 
diagnosis, normal otoscopy and a bilateral type A curve 
tympanometry. Patients could not have other diseases or 
evidence of intellectual, motor or other losses, except for 
those pertaining to Alport’s syndrome, to be included in 
our sample.
A detailed medical history was made, with an 
emphasis on hearing-related findings. The following exa-
ms were done: pure tone audiometry, logoaudiometry, 
which included the speech recognition threshold (SRT) 
and the percentage of speech recognition loss (IPRF), 
measurements of acoustic immitance (tympanometry and 
acoustic reflex thresholds), and transitory otoacoustic 
emissions (TOAE), with and with no contralateral acoustic 
stimulation. 
An MA-41 MAICO audiometer was used for pure 
tone audiometry, SRT, and IPRF. Chart 1 shows these 
measurements by sound frequency.
The device AZ-7 Interacoustic was used for acous-
tic immitance measures (tympanometry and contralateral 
acoustic reflex thresholds).
TOAE with and with no contralateral acoustic 
stimulation allowed us to assess the function of external 
ciliated cells (inner ear). Contralateral acoustic stimulation 
was continuous white noise transmitted by the MAICO 
17 audiometer, ANSI-69 standard, though a TDH-39 MX 
41 headphone. Recording was made using the ILO 92 - 
Otodynamics software. We first recorded TOAE with no 
contralateral stimulation, followed by recording of TOAE 
with contralateral white noise at 50 dB NPS. To obtain 
the TOAE suppression effect value, we measured the 
difference between global response (A) average values 
without and with contralateral acoustic stimulation. We 
then analyzed the influence of this noise by checking 
whether response amplitudes were reduced or not on 
TOAE recordings. 
We used the following non-parametric statistical 
tests: THE WILCOXON’S TEST, THE KRUSKAL-WALLIS 
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Chart 1 - Description of the hearing thresholds by sound frequency in subjects with Alport’s syndrome, for the right (OD) and left (OE) ears.
N Ear 250 500 1000 2000 3000 4000 6000 8000
1
OD 15 15 25 25 20 25 20 20
OE 10 15 20 20 25 25 25 15
2
OD 15 15 10 0 0 5 25 60
OE 25 20 10 0 0 5 40 20
3
OD AUS 100 115 AUS 120 AUS AUS AUS
OE 20 25 35 35 25 35 60 70
4
OD 35 40 55 65 60 55 55 50
OE 30 35 55 60 60 60 45 50
5
OD 35 40 55 65 65 65 50 40
OE 35 45 55 50 50 45 45 30
6
OD 50 50 50 70 70 70 80 65
OE 60 45 55 65 65 70 75 65
7
OD 30 25 15 10 0 10 45 30
OE 10 5 5 0 -5 0 10 20
8
OD 40 50 65 60 55 70 65 60
OE 35 40 55 60 55 60 75 65
9
OD 20 10 10 5 10 25 20 10
OE 25 15 5 5 20 35 30 5
10
OD 20 20 10 15 10 5 20 25
OE 15 15 10 10 5 0 20 25
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TEST AND THE MANN-WHITNEY TEST. We used a 0.10 
(10%) significance level in statistical comparisons. We 
also used the CONFIDENCE INTERVAL (95% of statistical 
confidence, 0.05 or 5%) technique to complete our des-
criptive analysis.
RESULTS
We studied the presence or absence of global 
responses (A) to TOAE (in dB) with and with no con-
tralateral acoustic stimulation by frequency range (1,000, 
1,500, 2,000, 3,000 and 4,000 Hz), and the suppression 
Table 1 - Results of the classification of presence (P) or absence (A), 
for TOAE with and without noise, and for the suppression effect (in 
dB), for each ear in the group with Alport’s syndrome.
Subjects
TOAE WITHOUT NOISE 
(dB)
TOAE WITH NOISE (
dB)
 OD OE OD OE
1 A A NR NR
2 P (14,0) P (14,2) P (13,6) P (11,7)
3 A A NR NR
4 A A NR NR
5 A A NR NR
6 A A NR NR
7 P (14,8) P (9,7) P (12,9) NR
8 A A NR NR
9 P (23,9) P (20,7) P (22,8) P (19,0)
10 P (9,7) P (13,9) P (10,4) P (13,2
NR: Not Done
P: Present
A: Absent
Table 2 - Average TOAE thresholds with no contralateral acoustic stimulation in subjects with TOAE, considering the global response (A), re-
producibility (R), stability (E) and response amplitude for the frequency range (in Hz) for the right ear (OD) and the left ear (OE).
EARS A R E 1k 1,5K 2k 3k 4k
OD 15,60 77,50 95,50 5,67 12,33 7,25 6,50 1,50
OE 14,63 79,75 92,75 6,50 6,75 10,00 9,25 -1,00
OD X OE P-VALUE 0,715 1,000 1,000 0,593 0,109 0,109 0,144 0,317
effect (in dB) for the right and left ear in ten patients with 
Alport’s syndrome. We found that four (40%) patients had 
TOAE response amplitude and six (60%) did not respond 
(Table 1). 
As a result of these findings, we analyzed the 
suppression effect only in patients with TOAE response 
amplitude.
We found that there was no statistically significant 
average difference between left and right ears for average 
values of TOAE response amplitude with no contralateral 
acoustic stimulation in patients with Alport’s syndrome. 
The TOAE response amplitude with no contralateral acous-
tic stimulation was seen in the global response (A) and at 
frequencies of 1,000, 1,500, 2,000 and 3,000 Hz (Table 2). 
We found no TOAE response amplitude at 4,000 Hz.
Descriptive TOAE measurements with no contra-
lateral acoustic stimulation were positive for the global 
response (A) and by frequency range at 1,000, 1,500, 2,000 
and 3,000 Hz, except for 4,000 Hz (Table 3).
We found that for the TOAE response amplitude 
with contralateral acoustic stimulation, there was no sta-
tistically significant difference between ears in the TOAE 
response amplitude with contralateral acoustic stimulation. 
The TOAE response amplitude with contralateral acoustic 
stimulation was present in the global response (A) and 
at 1,000, 1,500, 2,000 and 3,000 Hz, except for 4,000 Hz 
(Table 4).
            Analyzing descriptive TOAE measurements 
with contralateral acoustic stimulation, we saw that the 
global response global response (A) and the response at 
1,000, 1,500, 2,000 and 3,000 Hz was present except at 
4,000 Hz (Table 5). 
The suppression effect is characterized by a reduc-
tion in the TOAE response amplitude with contralateral 
acoustic stimulation. In our study we noted the suppression 
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Table 3 - Descriptive measurements of TOAE with no contralateral acoustic stimulation, in subjects with TOAE, considering the global respon-
se (A), reproducibility (R), stability (E) and response amplitude for the frequency range (in Hz).
INTENSITY (dB) A R E 1k 1,5K 2k 3k 4k
Average (dBNPS) 15,11 78,63 94,13 6,14 9,14 8,63 7,88 0,00
Standard Deviation 4,94 16,86 5,89 10,57 8,47 4,53 3,09 2,92
Size 8 8 8 7 7 8 8 5
Minimum Value 9,7 50 80 -5 -3 2 3 -2
Maximum Value 23,9 97 98 22 20 14 12 5
Table 4 - Average TOAE thresholds with contralateral acoustic stimulation in subjects with TOAE, considering the global response (A), reprodu-
cibility (R), stability (E) and response amplitude for the frequency range (in Hz) for the right ear (OD) and the left ear (OE).
EARS A R E 1k 1,5K 2k 3k 4k
OD 14,93 73,75 95,25 6,33 9,33 5,25 6,00 -0,50
OE 14,63 68,25 97,00 6,67 6,67 8,25 5,00 -1,00
OD X OE P-VALUE 0,989 0,885 0,557 0,827 0,658 0,559 0,655 0,978
Table 5 - Descriptive measurements of TOAE with contralateral acoustic stimulation, in groups with TOAE, considering the global response (A), 
reproducibility (R), stability (E) and response amplitude for the frequency range (in Hz).
INTENSITY (dB) A R E 1k 1,5K 2k 3k 4k
Average (dBNPS) 14,8 71,0 96,1 6,5 8,0 6,8 5,5 -0,8
Standard Deviation 4,4 21,2 2,6 7,6 5,7 6,3 2,1 3,0
Size 7 8 8 6 6 8 8 4
Minimum Value 11,5 56,3 94,3 0,5 3,4 2,4 4,1 -3,7
Maximum Value 18,1 85,7 98,0 12,5 12,6 11,1 6,9 2,2
Table 6 - Absence (A) and Presence (P) of the Suppression Effect of 
TOAE on subjects with Alport’s syndrome.
 Suppression Effect (dB)
Subjects OD OE
1 NR NR
2 0,4 2,5
3 NR NR
4 NR NR
5 NR NR
6 NR NR
7 1,9 9,7
8 NR NR
9 1,1 1,7
10 A 0,7
NR: Not Done
A: Absent
OD: right ear
OE: left ear
effect by looking at the difference between TOAE response 
amplitude values with and with no contralateral acoustic 
stimulation. This difference was interpreted as the presence 
of a suppression effect, when positive, and absence there-
of, when negative or absent. Furthermore, suppression was 
considered as positive in patients with Alport’s syndrome 
from a minimum average value of 0.1 dB, as this was the 
lowest published recorded value we found in specialized 
literature in audiologically normal subjects17,14,10 within 
the same age group as our sample. 
Among the four patients with TOAE response 
amplitude, three had the suppression effect bilaterally; in 
one patient, the suppression effect was present only in 
the left ear (Table 6).
Patients with Alport’s syndrome with TOAE res-
ponse amplitude had an average suppression value of 
0.31 dB. 
We found no TOAE response amplitude at 4,000 Hz, 
both with and with no contralateral acoustic stimulation. 
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DISCUSSION
Right and left ear responses with and with no con-
tralateral acoustic stimulation were statistically similar. 
Based on these findings, we may infer that when there is 
TOAE amplitude response, there is adequate global coch-
lear function, specifically of the external ciliated cells in 
patients with Alport’s syndrome. This is based on Kemp’s11 
(1978) report, which states that otoacoustic emissions ori-
ginate in the cochlea, specifically in the external ciliated 
cells, which respond mechanically to auditory stimulation, 
depending on the normal function of the cochlear trans-
duction process.
In our study, patients with Alport’s syndrome with 
TOAE response had average response amplitude values 
between 12 and 16 dB, within the normal range for normal 
adult and elderly individuals.18,9,12,6,16,4 The reduced 
or absent response at 4,000 Hz is also demonstrated in 
findings by Fenimam6 1993 and Sansone16  2000. 
Therefore, we may infer that in Alport’s syndrome, 
the presence of TOAE occurs in line with hearing loss.   
The medial olivocochlear efferent system (MOES) is 
responsible for keeping the basilar membrane in an opti-
mal position for transduction, for automatic gain control 
for external ciliated cells, as a protection system against 
loud noise, and for selective attention.
The MOES activity may be verified by the TOAE 
suppression effect. TOAE without and with contralateral 
noise allows us to respectively check the function of exter-
nal ciliated cells and MOES activity, which in turn allows 
us to establish a differential diagnosis between cochlear 
and retro-cochlear auditory dysfunction.
We found an average suppression effect value of 
0.31 dB in our group of patients with Alport’s syndro-
me and TOAE, similar to those of otologically normal 
adults,3,10,19,17,14 and lower than average values found 
in studies of term newborns15,5,20 with no risk of audi-
tory dysfunction. 
The presence of suppression suggests that when 
activated, MOES inhibits external ciliated cell contraction, 
leading to reduced TOAE amplitude in otologically normal 
individuals. This reduction is the measurement of MOES 
activity. We can thus infer MOES function, and whether 
it was adequate in our group of patients with Alport’s 
syndrome, eliminating the possibility of any retro-cochlear 
dysfunction.
CONCLUSION
Patients with Alport’s syndrome present TOAE 
results compatible with hearing loss. With TOAE there is 
also a suppression effect, suggesting that hearing loss is 
predominantly due to cochlear dysfunction. 
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